Trial intelligence / Profile preview

Ondansetron alone versus ondansetron + dexamethasone for nausea and vomiting after minor head trauma

IRCT20191127045526N1Phase 3Completed

Sponsor
Zahedan University of Medical Sciences
Start
Jan 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3, randomised, single-blind trial in Nausea and Vomiting comparing Ondansetron alone with Ondansetron + dexamethasone (2 arms). Primary endpoint: Treatment of nausea and vomiting. Started Jan 2020; status: completed.

02

Drugs

ondansetrondexamethasone
03

Conditions

Nausea and Vomiting

Beyond the preview

Go deeper on IRCT20191127045526N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191127045526N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call